INMD
InModeBNasdaq / Health Care Equipment & Services
Last Price
At close
2026-07-20
Current thesis
The constructive post-print read is that Q1 revenue slightly exceeded the company preannouncement range, management reiterated FY2026 revenue guidance, the U.S. contributed meaningfully to growth, and the company still holds a very large cash and investment position of $537.2 million while continuing aggressive buybacks.
Posture
Constructive
Lead driver
Value
What changed
Next scheduled catalyst: earnings 2026-07-23 · BMO.
What can break
Buybacks support the stock but can be modified, suspended, or discontinued and do not resolve core end-market demand risk.
Momentum
46
Value
72
Sentiment
49
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $14.50 · Bull $17.00 · Bear $11.50
Earnings
2026-07-23 · BMO
Data freshness
Prices
As of 2026-07-20
Fundamentals
As of 2026-07-20 • Vendor: Data Vendor v1
Scores
As of 2026-07-20 • Model: HYBRID_IC_RP
AI Memo
As of 2026-05-09 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-07-20
Investment thesis
As of 2026-07-20
Supporting evidence
What
Grade B · Constructive
Confidence Medium · Net Neutral
Target $15.33
Why
Momentum46 · Δ7d +6.0
Value72 · Δ7d -0.1
Sentiment49 · Δ7d -4.3
So what
Strength-led posture (Net Neutral). Favor watchlist adds and disciplined entries.
Lead driver: Value · See fundamentals
Momentum
46
26% active weight
Current posture
7d trendImproving
Δ7d
+6.0
Δ21d
+8.4
Value
72
39% active weight
Current posture
7d trendFlat
Δ7d
-0.1
Δ21d
+0.2
Sentiment
49
34% active weight
Current posture
7d trendSoftening
Δ7d
-4.3
Δ21d
-6.8
Why this grade
Composite grade B. Momentum 45.7 / Value 71.5 / Sentiment 48.5
Fundamentals (TTM)As of 2026-07-20
Fundamentals (TTM)
As of 2026-07-20
Market Cap
$882.9M
Beta
2.19
Shares Out
57.48M
P/E (TTM)
7.1
P/S (TTM)
2.63
P/FCF (TTM)
10.18
Rev YoY
+5.3%
EPS YoY
-31.0%
Gross Margin
+77.8%
Op Margin
+23.9%
Net Debt
-$547.11M
Current Ratio
8.80
As of 2026-07-20 • Updated nightlySource: Internal modelMethodology